期刊文献+

健脾补肾方对BALB/c鼠大肠癌肝转移模型中VEGF表达的影响 被引量:3

The Effects of Jian Pi Bu Shen Fang on the Expression of VEGF in the of BALB/c Mouse Model of Colorectal Liver Metastases
下载PDF
导出
摘要 目的:观察健脾补肾方是否对BALB/c鼠结直肠癌肝转移模型VEGF表达产生影响。方法:将40只大肠癌肝转移的BALB/c鼠随机区组分为生理盐水组、健脾补肾方高剂量组、健脾补肾方中剂量组、健脾补肾方低剂量组4组。健脾补肾方高剂量组43.7 g/(kg·d),健脾补肾方中剂量组21.85 g/(kg·d),健脾补肾方低剂量组10.925 g/(kg·d),对照组则予以生理盐水,4组均为0.2 m L/只,每天灌胃1次,共2周。根据各组HE染色观察肝脏的转移情况、免疫组化和Western blot测量每组的VEGF的表达。结果:HE染色观察:健脾补肾方中、高剂组肿瘤肝转移面积明显小于对照组,免疫组化及Western blot结果均表明健脾补肾方可以下调VEGF蛋白的表达水平(P<0.05)。结论:健脾补肾方可改善BALB/c鼠大肠癌肝转移的情况,可能通过降低VEGF的表达。 Objective:To study the effect of Jian Pi Bu Shen Fang(JPBSF)on the expression of VEGF in the BALB/c mouse with the model of CRC liver metastases. Methods:40 BALB/c mice cecal carcinoma in modeling,after modeling they were randomly Randomized blocked into the control group(0.9% normal saline),high dose group of JPBSF(43.7 g/kg),medium dose group(21.85 g/kg)and low dosage groups(10.925 g/kg).Every group has 10 mice. They were intragastric feed once every day,continuous administration of two weeks.Describe the liver metastases by HE staining and detect the expression of VEGF through immunohistochemistry and Western Blot. Results:The JPBSF groups obviously reduced the degree of liver metastases in high dose group and medium dose of JPBSF group compared with the control group by HE staining. Immunohistochemistry and Western blot results revealed that all groups of TCM reduce the expression of VEGF protein by JPBSF. Conclusion:JPBSF can improve the situation of liver metastases with of colorectal cancer in BALB/c mice,perhaps by the way to download the expression of VEGF.
出处 《辽宁中医药大学学报》 CAS 2015年第4期151-153,共3页 Journal of Liaoning University of Traditional Chinese Medicine
基金 上海市普陀区自主创新重大项目(2011PTKW001) 上海中医药大学"杏林学者"项目(B-X-73) 上海中医药大学中西医结合一流学科创新基金项目(B-X-72)
关键词 健脾补肾方 中医药 大肠癌 肝转移 血管内皮生长因子 JPBSF TCM colorectal cancer liver metastasis VEGF
  • 相关文献

参考文献13

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J ]. CA Cancer J Clin, 2011,61 ( 2 ): 69-90.
  • 2Hunter KW, Crawforrl NP, Alsarraj J. Mechanisms of metastasis [ J ] .Bast Cancer Res ,2008,10: S2.
  • 3Spiliotaki M, Markomanolaki H, Mela M, et al. Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel-mediated anti-tumor effect[ J ] .Lung Cancer, 2011,73 ( 2): 158-165.
  • 4Ebos JM, Kerbel RS. Antiangiogenie therapy : impact on invasion, disease progression, and metastasis[ J ] .Nat Rev Clin Oncol, 2011,8(4):210-221.
  • 5邓志红,孙珏.大肠癌中医辨证文献研究[J].云南中医学院学报,2011,34(2):54-56. 被引量:17
  • 6赵桂侠,郑坚,顾缨,朱莹杰.大肠癌中医证型的文献分析[J].辽宁中医药大学学报,2009,11(6):72-74. 被引量:30
  • 7杨剑锋,张森,高枫,陈利生.结直肠癌肝转移动物模型的建立[J].结直肠肛门外科,2009,15(3):139-143. 被引量:16
  • 8Lederle W, Hartenstein B, Meides A, et al. MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma [ J ] .Carcinogenesis, 2010,31 ( 7 ): 1175-1184.
  • 9Albo D, Rothman VL, Roberts DD, et el. Tumour cell thrombospondin-I regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor[ J ] .Br J Cancer, 2000,83 ( 3 ) : 298-306.
  • 10Law PC, Auyeung KK Chan LY, et al. Astragalus saponins dnwnregulate vascular endothelial growth factor under cobalt chloride-stimulated hypoxia in colon cancer cells[ J ] .BMC Complement Altern Med,2012,12: 160.

二级参考文献67

共引文献55

同被引文献55

  • 1许博文,李杰,高瑞珂,朱广辉,吴喆.基于“阳化气,阴成形”理论探讨肿瘤的中医辨治[J].中医杂志,2020,61(4):315-318. 被引量:79
  • 2王彦晖.中医和法在防治恶性肿瘤化疗毒副作用中的应用[J].甘肃中医学院学报,2004,21(3):9-11. 被引量:17
  • 3李正富.对“阳化气,阴成形”含义的探讨[J].浙江中医学院学报,2004,28(6):10-10. 被引量:49
  • 4郑红刚,朴炳奎.浅议放化疗毒副作用的中医病因[J].中国中医基础医学杂志,2007,13(10):751-752. 被引量:72
  • 5黄君兰.健脾补肾方联合熊去氧胆酸治疗原发性胆汁性肝硬化的临床观察[D].上海:上海中医药大学,2011.
  • 6WANG L, DU H, LIU Y, et al. Chinese medicine bu xu hua yu recipe for the regulation of treg/th17 ratio imbalance in au- toimmune hepatitis [ J ]. Evid Based Complement Alternat Med, 2015, 2015. 461294.
  • 7CHEN Y, FANG J, CHEN X, et al. Effects of the Treg/Th17 cell balance and their associated cytokines in patients with hepatitis B infection[J].Exp Ther Meal, 2015, 9(2) : 573 -578.
  • 8YANG CY, MA X, TSUNEYAMA K, et al. IL -12/Thl and IL -23/Th17 biliary microenvironment in primary biliary cirrho- sis : implications for therapy[ J ]. Hepatology, 2014, 59( 5 ) ~ 1944 - 1953.
  • 9ZHOU L, IVANOV II, SPOLSKI R, et al. IL -6 programs T ( H ) - 17 cell differentiation by promoting sequential engage- ment of the IL -21 and IL -23 pathways[J]. Nat Immunol, 2007, 8(9) : 967 -974.
  • 10RONG G, ZHOU Y, XIONG Y, et al. Imbalance between T help- er type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell popula- tion[J]. Clin Exp Immunol, 2009, 156 (2] : 217 -225.

引证文献3

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部